Non-Alcoholic Fatty Liver Disease: The Emerging Burden in Cardiometabolic and Renal Diseases.
about
Obesity induced alterations in redox homeostasis and oxidative stress are present from an early age.The Sodium-Glucose Cotransporter 2 Inhibitor Dapagliflozin Prevents Renal and Liver Disease in Western Diet Induced Obesity Mice.Capybara Oil Improves Hepatic Mitochondrial Dysfunction, Steatosis, and Inflammation in a Murine Model of Nonalcoholic Fatty Liver Disease.Association of sex hormone-binding globulin with nonalcoholic fatty liver disease in Chinese adults
P2860
Non-Alcoholic Fatty Liver Disease: The Emerging Burden in Cardiometabolic and Renal Diseases.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Non-Alcoholic Fatty Liver Dise ...... ometabolic and Renal Diseases.
@en
Non-Alcoholic Fatty Liver Dise ...... ometabolic and Renal Diseases.
@nl
type
label
Non-Alcoholic Fatty Liver Dise ...... ometabolic and Renal Diseases.
@en
Non-Alcoholic Fatty Liver Dise ...... ometabolic and Renal Diseases.
@nl
prefLabel
Non-Alcoholic Fatty Liver Dise ...... ometabolic and Renal Diseases.
@en
Non-Alcoholic Fatty Liver Dise ...... ometabolic and Renal Diseases.
@nl
P2860
P1476
Non-Alcoholic Fatty Liver Dise ...... ometabolic and Renal Diseases.
@en
P2093
Eugene Han
P2860
P304
P356
10.4093/DMJ.2017.41.6.430
P50
P577
2017-11-17T00:00:00Z